TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 DKK)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
517
|
798
|
543 |
| Financial expenses |
72
|
280
|
297 |
| Earnings before taxes |
-75
|
62
|
48 |
| EBITDA |
-11
|
342
|
337 |
| Total assets |
9,555
|
9,503
|
10,549 |
| Current assets |
503
|
734
|
651 |
| Current liabilities |
168
|
246
|
189 |
| Equity capital |
9,343
|
9,187
|
10,277 |
| - share capital |
66
|
63
|
70 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
97.8%
|
96.7%
|
97.4% |
| Turnover per employee |
517
|
798
|
543 |
| Profit as a percentage of turnover |
-14.5%
|
7.8%
|
8.8% |
| Return on assets (ROA) |
0.0%
|
3.6%
|
3.3% |
| Current ratio |
299.4%
|
298.4%
|
344.4% |
| Return on equity (ROE) |
-0.8%
|
0.7%
|
0.5% |
| Change turnover |
-313
|
306
|
207 |
| Change turnover % |
-38%
|
62%
|
61% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.